Bizarre Patents
Method and apparatus for making a drink hop along a bar or counter
A method for generating a drink which appears to hop from a remote spot on the bar or counter and take one or more leaps, before landing in a patron's glass.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7399320 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds The invention concerns the use as direct dyeing agent of at least one tetra-azapentamethine compound, a dyeing composition comprising at least such a compound, as well as a method for dyeing keratinous fibers, in particular human keratinous fibers and more particula... | 07/15/2008 |
| 7288122 | Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor The present disclosure relates to cationic diazo dye compounds of formula (I): Dye1-LK-Dye2, (I) dye compositions comprising the direct dye compounds, and also to a process for dyeing keratin fibers using this composition and a multi-compar... | 10/30/2007 |
| 7285138 | Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore The present disclosure relates to a cationic diazo compound of formula (I): Dye1-LK-Dye2 wherein Dye1 and Dye2 are such that the compound of formula (I) is not symmetrical, and are chosen from: | 10/23/2007 |
| 7164027 | Aralkyl ester soft drugs The present invention describes a method for programming a specific course and rate of metabolism for a parent drug compound that leads to an inactive or very weakly active and nontoxic metabolite when the modified drug compound is administered. The parent drug comp... | 01/16/2007 |
| 7144908 | Agonists of beta-adrenoceptors The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases. | 12/05/2006 |
| 7077873 | Composition for the dyeing of human keratinous fibres comprising a monocationic monoazo dye A subject-matter of the disclosure is a novel composition for the dyeing of human keratinous fibres, for example, the hair, comprising a monocationic monoazo dye of formula (I) W1-N═N—W2-NW3-W4-W5, the dyeing processes employing it, the use of the dyes of formul... | 07/18/2006 |
| 7022143 | Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye The invention concerns a novel dyeing composition for dyeing keratinous fibers, in particular human hair, comprising a cationic azo-dye of formula (I): W1—N═N—W2—W3, as well as the dyeing method using said composition and the novel compounds of formula (I). | 04/04/2006 |
| 7009048 | Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye A dye-forming coupler of the formula (I). A silver halide photographic light-sensitive material that contains at least one dye-forming coupler of the formula (I). A method for producing an azomethine dye, which method comprises using a compound of the formula (I): | 03/07/2006 |
| 6893471 | Dyeing composition for keratinous fibers comprising a particular dicationic diazo dye The invention concerns a dyeing composition for dyeing keratinous fibers, in particular human keratinous fibers and more particularly hair, comprising a dicationic diazo dye of formula W1—N═N—W2—N═N—W3 as well as the dyei... | 05/17/2005 |
| 6884265 | Dyeing composition for dyeing keratinous fibers comprising at least one particular dicationic diazo dye The invention concerns a novel dyeing composition for dyeing keratinous fibers, in particular human hair, comprising a dicationic diazo dye of formula (I): W1—W2—N═N—W3—L—W4—N═N—W5—W6, as well as the dyeing method using said composition and the n... | 04/26/2005 |
| 6884267 | Dyeing composition for dyeing keratinous fibers comprising at least one cationic azo-dye The invention concerns a novel dyeing composition for dyeing keratinous fibers, in particular human hair, comprising a cationic azo-dye of formula (I): W1—N═N—W2—W3, as well as the dyeing method using said composition and the novel compounds of formula (I). | 04/26/2005 |
| 6884266 | Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye The invention concerns a novel dyeing composition for dyeing keratinous fibers, in particular human hair, comprising a cationic azo dye of formula (I): W1—N═N—W2—NW3W4, and the dyeing method using said composition ... | 04/26/2005 |
| 6881230 | Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye The invention concerns a novel dyeing composition for dyeing keratinous fibers, in particular human hair, comprising a cationic azo-dye of formula (I): W1-N═N-W2-W3, as well as the dyeing method using said composition and the novel compounds of formula (I). ... | 04/19/2005 |
| 6683190 | Method for preparing chiral amino acids The invention concerns a novel method for preparing chiral amino acids of formula (I) characterised in that it consists in contracting a racemic hydantoin of formula (II) with an enantiomeric splitting agent. ##STR1##... | 01/27/2004 |
| 6630599 | Process for preparing derivatives of isopropenyl-, -dimethylbenzyl isocyanate A process for preparing blocked derivatives of m- or p- isopropenyl-,-dimethylbenzyl isocyanates, comprising reacting a meta- or a para-isopropenyl-,-dimethylbenzyl carbamate ester with hydroxy functional blocking group, such a... | 10/07/2003 |
| 6476202 | 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol compounds and method of using them Disclosed is a 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol having the structural formula I: ##STR1## wherein: R* is an arylazo, nitro, or nitroso group, Y is a coupling-off group, and R' is a substituent group. Also disclosed is a method of u... | 11/05/2002 |
| 6472415 | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes Substituted phenylalanines are provided comprising an hydantoin, urea or 2-hydroxyl, 2-methylpropionyl group, dimers thereof and alkyl, polyfluoroamido and haloarylamino derivatives thereof, as well as radiolabeled derivatives thereof. The compounds bind ... | 10/29/2002 |
| 6384061 | Hydantoin compounds and methods related thereto The present invention relates to novel hydantoin compounds represented by formula (I) which shows an inhibitory activity against farnesyl transferase, and thus can be used as an anti-cancer agent, or pharmaceutically acceptable salts thereof, in which R | 05/07/2002 |
| 6355664 | Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules. Exemplary of the novel compounds are those of the following structural formulas: ##STR1## ##STR2##... | 03/12/2002 |
| 6320055 | Process for preparing hydantoins or cyclic anhydrides of an amino acid Process for preparing compounds of the formula I ##STR1## in which R is alkyl or aryl, in each case unsubstituted or substituted, R3 is hydrogen, alkyl or aryl, in each case unsubstituted or substituted, and X.dbd.O or NH, which comprises react... | 11/20/2001 |
| 6294694 | Matrix metalloproteinase inhibitors and method of using same Peptoid compounds of Formula I and Formula II are disclosed ##STR1## The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.... | 09/25/2001 |
| 6245917 | Crystalline sodium phenytoin monohydrate Crystalline sodium phenytoin monohydrate is stable, nonhygroscopic, and water soluble.... | 06/12/2001 |
| 6242611 | Phenylimidazolidines containing nitrooxy or carbonyloxy groups A subject of the invention is the products of formula (I): ##STR1## in which: R1 and R2 represent in particular cyano and trifluoromethyl, R3 represents in particular alkyl, alkenyl or alkynyl, substituted in particular by nitr... | 06/05/2001 |
| 6107488 | Phenylimidazolidine preparation process A subject of the invention is a preparation process for the products of formula (I): ##STR1## in which R1 and R2 represent in particular hydrogen, cyano, halogen or amino,R3 represents in particular hydrogen or hydrox... | 08/22/2000 |
| 6087509 | 1-Imidazolidinyl-phenyls A particular subject of the invention is the products of formula (I): ##STR1## in which: R1 and R2 represent in particular cyano and trifluoromethyl, R3 represents in particular alkyl, alkenyl or alkynyl, optionally s... | 07/11/2000 |
| 6054591 | Lymph-absorbable aryl substituted imidazole derivatives A compound of the formula (I): ##STR1## salt thereof, or hydrate thereof which can effectively be absorbed from the lymph vessel in the intestinal tract and transferred to the lymph node in a high concentration is provided.... | 04/25/2000 |
| 6034238 | Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists Compounds of the formula I, ##STR1## in which B, E, W, Y, Z, R, R2, R2a, R2b, R3, g and h have the meanings indicated in the specifications. The compounds of the formula I are valuable pharmaceutical active... | 03/07/2000 |
| 5939556 | Hydantoin compounds, salts thereof, processes for their preparation, and processes for preparing pharmaceutically active compounds comprising them The present invention relates to hydantoin derivatives of the formula I ##STR1## and which are intermediates for the preparation of pharmaceutical active compounds, their preparation and their use in the preparation of the active compounds.... | 08/17/1999 |
| 5929249 | Substituted imidazolyl-alkyethio-aldanoic acids Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and m... | 07/27/1999 |
| 5877324 | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives The compound of formula I: ##STR1## wherein R is phenyl or phenyl optionally substituted with one or more groups selected from halogen, alkyl, perfluoroalkyl, alkoxy, perfluoroalkoxy, hydroxy, alkanoyloxy, aroyloxy or arylalkanoyloxy; R3 | 03/02/1999 |
| 5861517 | 2-thioxo-imidazolidin-4-one derivatives The compound of formula I: ##STR1## in which R1 is alkyl or alkenyl; R2 is alkyl and R3 and R4 are, independently, hydrogen or alkyl; or R2 is hydrogen and R3 and R4 taken t... | 01/19/1999 |
| 5817685 | Anticonvulsive imidazoline-2,4-diones and process for making Anticonvulsive compounds and compositions, of the formula ##STR1## in which X is a C1-4 -alkyl, trifluoromethyl, or halogen residue, Y is hydrogen or halogen, n is 0 or 1, and m is 0 or a cardinal number from 1 to 4, and its pharmacologica... | 10/06/1998 |
| 5783707 | 2-thioxo-imidazolidin-4-one derivatives The compound of formula I ##STR1## in which R1 is alkyl; and R is alkyl, naphthyl, benzhydryl, fluorophenylmethyl, phenethyl, 1-(fluorophenyl)ethyl, 5-chloro-2-methoxyphenyl, trifluoromethoxyphenyl, trifluoromethylphenyl, methylsulfan... | 07/21/1998 |
| 5750553 | Optionally substituted phenylimidazolidines, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them A compound in all possible racemic, enantiomeric and diastereoisomer forms of the formula ##STR1## wherein Y is --O--, Z2 is --CF3, Z1 is --CN or --NO2, X is --O-- or --S--, R3 is hydrogen or alk... | 05/12/1998 |
| 5744602 | Certain imidazoquinoxalines; a new class of GABA brain receptor ligands The invention encompasses compounds of the formula: ##STR1## and the pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, and X are variables; and W is phenyl optionally substituted with straight or... | 04/28/1998 |
| 5728842 | Substituted imidazolyl-alkylthio-alkanoic acids Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and m... | 03/17/1998 |
| 5663363 | 2-thioxo-imidazolidin-4-one derivatives The compound of formula I ##STR1## in which R is alkynyl; and X and Y are, independently, alkyl, halo, perfluoralkyl, perfluoralkoxy, or, taken together, X and Y are ortho substituted trimethylene or tetramethylene are useful for increasing blood ... | 09/02/1997 |
| 5656651 | Androgenic directed compositions Substituted phenylthiohydantoins are provided for use in detecting the presence of tumor cells having androgenic receptors and providing for cytostatic and cytotoxic activity toward such cells. The subject compounds provide for vehicles for specific targe... | 08/12/1997 |
| 5650424 | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them The invention relates to cyclic urea derivatives of general formula ##STR1## wherein Ra, Rb, X and Y are as defined herein, pharmaceutical compositions containing the derivatives and processes for preparing them.... | 07/22/1997 |
| 5627201 | Phenylimidazolidines having antiandrogenic activity A compound of the formula ##STR1## wherein R1 is selected from the group consisting of --CN, --NO2 and halogen, R2 is --CF3 or halogen, --A--B-- is selected from the group consisting of ##STR2## X... | 05/06/1997 |
